RCA
Roberts Capital Advisors Portfolio holdings
AUM
$89.9M
1-Year Est. Return
32.86%
1 Year Est. Return
+32.86%
AUM
$135M
AUM Growth
+$21M
(+18%)
Holding
84
Top Buys
| 1 | +$1.15M | |
| 2 | +$779K | |
| 3 | +$271K | |
| 4 |
DaVita
DVA
|
+$253K |
| 5 |
Morgan Stanley
MS
|
+$249K |
Top Sells
| 1 | +$644K | |
| 2 | +$551K | |
| 3 | +$490K | |
| 4 |
Johnson & Johnson
JNJ
|
+$477K |
| 5 |
Cooper Companies
COO
|
+$422K |
Sector Composition
| 1 | Technology | 45.43% |
| 2 | Communication Services | 13.96% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.46% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NXP Semiconductors
NXPI
$59.7B
| $484K | 0.36% |
2,216
|
|
||
77
Vertex Pharmaceuticals
VRTX
$112B
| $216K | 0.16% |
485
-89
|
|
||
78
Advanced Micro Devices
AMD
$377B
| $213K | 0.16% |
+1,501
|
|
||
|
79
Cooper Companies
COO
$16.1B
| – | – |
-5,004
|
|
||
80
Gilead Sciences
GILD
$155B
| – | – |
-2,920
|
|
||
81
HCA Healthcare
HCA
$107B
| – | – |
-1,865
|
|
||
|
82
Johnson & Johnson
JNJ
$527B
| – | – |
-2,876
|
|
||
83
Merck
MRK
$270B
| – | – |
-6,141
|
|
||
84
Abbott
ABT
$212B
| – | – |
-3,693
|
|